Marshall Wace’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,557
Closed -$173K 2943
2024
Q4
$173K Buy
+23,557
New +$173K ﹤0.01% 2216
2023
Q3
Sell
-73,641
Closed -$1.81M 2360
2023
Q2
$1.81M Sell
73,641
-9,920
-12% -$243K ﹤0.01% 1184
2023
Q1
$1.94M Sell
83,561
-114,429
-58% -$2.66M ﹤0.01% 1170
2022
Q4
$5.01M Sell
197,990
-148,286
-43% -$3.75M 0.01% 1017
2022
Q3
$6.68M Buy
346,276
+90,200
+35% +$1.74M 0.01% 1037
2022
Q2
$6.52M Buy
+256,076
New +$6.52M 0.01% 1057
2022
Q1
Sell
-352,171
Closed -$14.7M 3359
2021
Q4
$14.7M Buy
352,171
+293,552
+501% +$12.3M 0.03% 573
2021
Q3
$2.55M Buy
+58,619
New +$2.55M 0.01% 1108
2021
Q2
Sell
-39,560
Closed -$2.03M 2585
2021
Q1
$2.03M Buy
+39,560
New +$2.03M 0.01% 1139